Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
HEICO Corp Class A
HEI.A
$37.2B
| $60.5M | 0.02% |
517,019
-665,256
| -56% | -$72.4M |
|
977
CALL
IBM
IBM
$222B
| $60.4M | 0.02% |
502,185
+49,267
| +11% | +$5.69M |
|
978
Realty Income
O
$58.7B
| $60.3M | 0.02% |
1,001,280
-1,012,248
| -50% | -$59.8M |
|
979
Arista Networks
ANET
$240B
| $60.3M | 0.02% |
3,317,840
-94,448
| -3% | -$1.5M |
|
980
Timken Company
TKR
$9.18B
| $60.2M | 0.02% |
778,373
-252,353
| -24% | -$17.2M |
|
981
CALL
Qualcomm
QCOM
$171B
| $60.2M | 0.02% |
394,900
+52,000
| +15% | +$7.24M |
|
982
Federal Signal
FSS
$8.09B
| $60M | 0.02% |
1,808,304
+436,857
| +32% | +$13.8M |
|
983
DTE Energy
DTE
$29.5B
| $59.9M | 0.02% |
579,328
-480,662
| -45% | -$50.7M |
|
984
Arrow Electronics
ARW
$11.6B
| $59.7M | 0.02% |
613,479
-38,426
| -6% | -$3.4M |
|
985
NovoCure
NVCR
$1.89B
| $59.5M | 0.02% |
344,055
+148,277
| +76% | +$20.3M |
|
|
PRAH
986
DELISTED
PRA Health Sciences, Inc.
PRAH
| $59.5M | 0.02% |
474,558
-52,466
| -10% | -$5.87M |
|
|
BZUN
987
Baozun
BZUN
$176M
| $59.5M | 0.02% |
1,731,765
+251,188
| +17% | +$9.21M |
|
988
Ollie's Bargain Outlet
OLLI
$4.66B
| $59.5M | 0.02% |
727,411
-394,105
| -35% | -$34.4M |
|
989
Westlake Corp
WLK
$10.3B
| $59.4M | 0.02% |
728,009
-166,567
| -19% | -$12.4M |
|
990
Diageo
DEO
$48.8B
| $59.3M | 0.02% |
373,630
+10,883
| +3% | +$1.62M |
|
991
CALL
Wells Fargo
WFC
$267B
| $59.2M | 0.02% |
1,962,500
+891,400
| +83% | +$23.1M |
|
992
Atlantic Union Bankshares
AUB
$6.16B
| $59M | 0.02% |
1,792,206
-101,304
| -5% | -$2.91M |
|
993
Ionis Pharmaceuticals
IONS
$9.15B
| $59M | 0.02% |
1,044,054
+453,994
| +77% | +$22.6M |
|
994
Sumitomo Mitsui Financial
SMFG
$158B
| $58.9M | 0.02% |
9,543,041
+2,224,548
| +30% | +$13.1M |
|
995
iShares National Muni Bond ETF
MUB
$45.4B
| $58.9M | 0.02% |
502,256
-915
| -0.2% | -$106K |
|
996
Gartner
IT
$12.4B
| $58.9M | 0.02% |
367,387
-276,206
| -43% | -$39.8M |
|
997
Dr. Reddy's Laboratories
RDY
$10.1B
| $58.8M | 0.02% |
4,126,950
-2,491,730
| -38% | -$33.6M |
|
998
Denali Therapeutics
DNLI
$3.84B
| $58.8M | 0.02% |
702,394
+196,852
| +39% | +$11.9M |
|
999
CALL
Caterpillar
CAT
$404B
| $58.8M | 0.02% |
322,900
-59,000
| -15% | -$10M |
|
1000
United Therapeutics
UTHR
$22B
| $58.7M | 0.02% |
386,741
-45,171
| -10% | -$5.93M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 644 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.